Literature DB >> 23827393

Will imaging biomarkers transform spinal cord injury trials?

David W Cadotte1, Michael G Fehlings2.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23827393     DOI： 10.1016/S1474-4422(13)70157-1

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  12 in total

Review 1.  Application of electrophysiological measures in spinal cord injury clinical trials: a narrative review.

Authors:  Michèle Hubli; John L K Kramer; Catherine R Jutzeler; Jan Rosner; Julio C Furlan; Keith E Tansey; Martin Schubert
Journal:  Spinal Cord       Date:  2019-07-23       Impact factor: 2.772

2.  Characterizing the location of spinal and vertebral levels in the human cervical spinal cord.

Authors:  D W Cadotte; A Cadotte; J Cohen-Adad; D Fleet; M Livne; J R Wilson; D Mikulis; N Nugaeva; M G Fehlings
Journal:  AJNR Am J Neuroradiol       Date:  2014-12-18       Impact factor: 3.825

Review 3.  Translating state-of-the-art spinal cord MRI techniques to clinical use: A systematic review of clinical studies utilizing DTI, MT, MWF, MRS, and fMRI.

Authors:  Allan R Martin; Izabela Aleksanderek; Julien Cohen-Adad; Zenovia Tarmohamed; Lindsay Tetreault; Nathaniel Smith; David W Cadotte; Adrian Crawley; Howard Ginsberg; David J Mikulis; Michael G Fehlings
Journal:  Neuroimage Clin       Date:  2015-12-04       Impact factor: 4.881

4.  Clinical Utility of Diffusion Tensor Imaging as a Biomarker to Identify Microstructural Changes in Pediatric Spinal Cord Injury.

Authors:  Laura Krisa; Devon M Middleton; Sona Saksena; Scott H Faro; Benjamin E Leiby; Feroze B Mohamed; M J Mulcahey
Journal:  Top Spinal Cord Inj Rehabil       Date:  2022-04-12

Review 5.  Concise Review: Bridging the Gap: Novel Neuroregenerative and Neuroprotective Strategies in Spinal Cord Injury.

Authors:  Christopher S Ahuja; Michael Fehlings
Journal:  Stem Cells Transl Med       Date:  2016-04-29       Impact factor: 6.940

Review 6.  Recent advances in managing a spinal cord injury secondary to trauma.

Authors:  Christopher S Ahuja; Allan R Martin; Michael Fehlings
Journal:  F1000Res       Date:  2016-05-27

Review 7.  Guidelines for the conduct of clinical trials in spinal cord injury: Neuroimaging biomarkers.

Authors:  Maryam Seif; Claudia Am Gandini Wheeler-Kingshott; Julien Cohen-Adad; Adam E Flanders; Patrick Freund
Journal:  Spinal Cord       Date:  2019-07-02       Impact factor: 2.772

Review 8.  Traumatic and nontraumatic spinal cord injury: pathological insights from neuroimaging.

Authors:  Gergely David; Siawoosh Mohammadi; Allan R Martin; Julien Cohen-Adad; Nikolaus Weiskopf; Alan Thompson; Patrick Freund
Journal:  Nat Rev Neurol       Date:  2019-10-31       Impact factor: 42.937

9.  Progressive neurodegeneration following spinal cord injury: Implications for clinical trials.

Authors:  Gabriel Ziegler; Patrick Grabher; Alan Thompson; Daniel Altmann; Markus Hupp; John Ashburner; Karl Friston; Nikolaus Weiskopf; Armin Curt; Patrick Freund
Journal:  Neurology       Date:  2018-03-07       Impact factor: 9.910

10.  Relevance of time-dependence for clinically viable diffusion imaging of the spinal cord.

Authors:  Francesco Grussu; Andrada Ianuş; Carmen Tur; Ferran Prados; Torben Schneider; Enrico Kaden; Sébastien Ourselin; Ivana Drobnjak; Hui Zhang; Daniel C Alexander; Claudia A M Gandini Wheeler-Kingshott
Journal:  Magn Reson Med       Date:  2018-09-05       Impact factor: 4.668
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.